GGrantIndex
Sort

21,281 grants matching influenza

Mechanisms of Recovery from Viral Pneumonia

$2,750,594
Karen M Ridge · Northwestern University At Chicago · P01 · FY2023 · HL

IP21-002, Surveillance for Vaccine Preventable Disease in Children

$2,750,000
Julie Anne Boom · Baylor College Of Medicine · U01 · FY2023 · IP

IP21-002 Enhanced Surveillance for New Vaccine Preventable Diseases

$2,750,000
Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2023 · IP

IP21-002, Enhanced Surveillance Network for Enteric and Respiratory Viruses in Children: Assessing Disease Burden, Natural History, and Vaccine Effectiveness

$2,750,000
Geoffrey Alan Weinberg · University Of Rochester · U01 · FY2023 · IP

IP21-002, New Vaccine Surveillance Network

$2,750,000
John V Williams · University Of Pittsburgh At Pittsburgh · U01 · FY2023 · IP

IP21-002 US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children

$2,749,997
Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2023 · IP

IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children

$2,749,996
Rangaraj Selvarangan · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2023 · IP

IP21-002, Enhanced Surveillance to Assess Vaccine Preventable Enteric and Respiratory Virus Illnesses

$2,749,994
Janet A Englund · Seattle Children'S Hospital · U01 · FY2023 · IP

Strengthening Avian Influenza Surveillance & Pandemic Influenza Preparedness Plan

$2,739,536
David Mercer · World Health Organization · U51 · FY2009 · CI

Center for Rapid Influenza Surveillance and Research

$2,736,871
University Of California Los Angeles · N01 · FY2008 · AI

University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)

$2,736,516
Ann R Falsey · University Of Rochester · UM1 · FY2022 · AI

Aging Intervention Studies

$2,736,062
Julie Mattison · National Institute On Aging · ZIA · FY2023 · AG

Adjuvant Discovery for Vaccines against Influenza Virus

$2,730,922
Ofer Levy · Boston Children'S Hospital · N01 · FY2018 · AI

Systems Immune Profiling of Divergent Responses to Infection

$2,727,875
David A. Hafler · Yale University · U19 · FY2017 · AI

Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross

$2,727,484
Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2018 · AI

MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESOURCE REPOSITORY (MID-BRR)

$2,722,642
Timothy T Stedman · American Type Culture Collection · N01 · FY2014 · AI

Omics-Based Predictive Modeling of Age-Dependent Outcome to Influenza Infection

$2,714,464
Elodie Ghedin · New York University · U01 · FY2017 · AI

Development of vaccines to bacterial diseases found especially in children

$2,713,785
John Robbins · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD

Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required)

$2,708,294
Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr · UM1 · FY2022 · AI

DEVELOPMENT OF BROAD SPECTRUM ANTIVIRALS

$2,707,876
Urban Hans Ramstedt · Unither Virology, Llc · N01 · FY2012 · AI

Immune signatures of vaccine responses in vulnerable populations

$2,706,289
Ruth R Montgomery · Yale University · U19 · FY2023 · AI

Biology and structure of pMHC receptors functioning as mechanosensors in the [alpha][beta] T-cell lineage

$2,705,373
Ellis L Reinherz · Dana-Farber Cancer Inst · P01 · FY2025 · AI

Structure-function analysis of infection- and vaccine-induced B-cell repertoires

$2,701,758
Stephen C Harrison · Boston Children'S Hospital · P01 · FY2021 · AI

Computational Models of Infectious Disease Threats

$2,697,739
Donald S. Burke · University Of Pittsburgh At Pittsburgh · U54 · FY2009 · GM

Enhancing SEBLAB Research Productivity, Operations and Core Laboratory Support

$2,691,731
Sixto Manuel Leal · University Of Alabama At Birmingham · UC7 · FY2023 · AI